Kerrisdale believes that Prothena's lead drug NEOD001 will fail in its current Phase 2b and Phase 3 trials. Source: BioSpace

Exonics Therapeutics closed on a $40M Series A financing which was led by The Column Group. Source: BioSpace

The hearing will focus on the therapeutic potential and ethical issues of using CRISPR technology to alter human DNA. Source: BioSpace

Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college. Source: BioSpace

Approval is based on Phase III results that showed Alecensa extended the average time that people lived without their disease worsening compared to crizotinib. Source: BioSpace

Harris fired the first shots on Monday. Source: BioSpace

Takeda inked a collaboration deal to develop and commercialize Portal's needle-free drug delivery device for use with some of Takeda's biologic medicines. Source: BioSpace

Bristol-Myers is initiating a Phase III clinical trial of BMS-986205 with nivolumab in patients with advanced melanoma. Source: BioSpace

The increased funding showcases investor confidence in Counsyl’s leading genetic screening products and business model. Source: BioSpace

People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option. Source: BioSpace